99 reports of this reaction
3.1% of all SODIUM POLYSTYRENE SULFONATE reports
#3 most reported adverse reaction
ACUTE KIDNEY INJURY is the #3 most commonly reported adverse reaction for SODIUM POLYSTYRENE SULFONATE, manufactured by ANI Pharmaceuticals, Inc.. There are 99 FDA adverse event reports linking SODIUM POLYSTYRENE SULFONATE to ACUTE KIDNEY INJURY. This represents approximately 3.1% of all 3,148 adverse event reports for this drug.
Patients taking SODIUM POLYSTYRENE SULFONATE who experience acute kidney injury should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ACUTE KIDNEY INJURY is moderately reported among SODIUM POLYSTYRENE SULFONATE users, representing a notable but not dominant share of adverse events.
In addition to acute kidney injury, the following adverse reactions have been reported for SODIUM POLYSTYRENE SULFONATE:
The following drugs have also been linked to acute kidney injury in FDA adverse event reports:
ACUTE KIDNEY INJURY has been reported as an adverse event in 99 FDA reports for SODIUM POLYSTYRENE SULFONATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ACUTE KIDNEY INJURY accounts for approximately 3.1% of all adverse event reports for SODIUM POLYSTYRENE SULFONATE, making it one of the most commonly reported side effect.
If you experience acute kidney injury while taking SODIUM POLYSTYRENE SULFONATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.